Basic
$2.99/mo
A focused membership for joining the clinical neuroscience conversation.
- Discussion access
- Author articles at $0.99 each
Evidence-led neuroscience reviews
Go deeper with evidence-led neuroscience reviews, trusted references, and clinical context—become a member to unlock more.
Membership unlocks complete, evidence-conscious reviews and article-specific reference lists for clinicians, researchers, trainees, and advanced learners.
Explore brain and spinal cord mechanisms, disease biology, neuropharmacology, neurodegeneration, and traumatic injury.
Three access levels from $2.99/month.
Educational content only; not medical advice, diagnosis, or individualized treatment guidance.
Start with the right depth
Compare live access levels before you enter the archive.
These are the current membership plans. Each unlocks a different level of access to complete reviews and their article-specific reference lists where available.
Compare plans and subscribeAdvanced
$5.99/mo
Expanded access for deeper evidence-led study.
- Everything in Basic
- NIH/PMC articles
Premium
$9.99/mo
Complete access to the Neuronova Project library.
- Everything in Basic and Advanced
- Unlimited website article access
Inside the member archive
Premium reviews designed for close, clinically grounded reading.
Editorial preview
Mechanisms of secondary injury after traumatic brain injury
Follow cellular injury cascades from the initial insult through inflammatory signaling, metabolic stress, and the clinical questions each stage can—and cannot—answer.
Traumatic brain injury12 min read
See this and other article abstracts What membership unlocks
Public abstracts show the question. Membership adds the complete review and its article-specific reference list where available.
Compare membership tiersSynaptic signaling
Glutamate, GABA, and the balance between excitation and injury
Trace neurotransmitter systems, receptor pharmacology, and the mechanisms that make excitotoxicity clinically consequential.
Developmental neuroscience
Neural tube development, neural stem cells, and repair
Connect embryologic patterning with adult neurogenesis and the possibilities—and limits—of neural stem cell therapeutics.
Neurodegeneration
Protein aggregation, CRISPR, and the future of Alzheimer’s care
Examine amyloid and tau biology alongside prospective interventions, trial interpretation, and realistic patient outlooks.
Movement disorders
Parkinson’s disease beyond dopamine
Read a systems-level review of α-synuclein, selective vulnerability, non-motor disease, and treatment evidence.
Editorial approach
Context before conclusions.
The Neuronova Project makes scope, dates, authorship, and source material easy to identify. It does not present educational content as individualized clinical direction.
Mechanisms with clinical context
Reviews connect molecular and systems-level mechanisms with the questions they inform, without turning association into certainty.
References that stay with the article
Source lists and updates remain paired with their own reviews so readers can evaluate the material in its proper context.
Educational use only
Material on this site is informational and educational. It is not medical advice, a diagnosis, or treatment guidance, and should not replace professional judgment or consultation.
Begin with the right depth